AAAAAA

   
Results: 1-3 |
Results: 3
Use of human skin equivalent Apligraf for in vitro assessment of cumulative skin irritation potential of topical products
Authors: Medina, J de Fraissinette, AD Chibout, SD Kolopp, M Kammermann, R Burtin, P Ebelin, ME Cordier, A
Citation: J. Medina et al., Use of human skin equivalent Apligraf for in vitro assessment of cumulative skin irritation potential of topical products, TOX APPL PH, 164(1), 2000, pp. 38-45
Oral SDZ ASM 981: safety, pharmacokinetics and efficacy in patients with moderate to severe chronic plaque psoriasis (vol 143, pg 61, 2000)
Authors: Rappersberger, K Komar, M Ebelin, ME Scott, G Bueche, M Burtin, P Wolff, K
Citation: K. Rappersberger et al., Oral SDZ ASM 981: safety, pharmacokinetics and efficacy in patients with moderate to severe chronic plaque psoriasis (vol 143, pg 61, 2000), BR J DERM, 143(5), 2000, pp. 1130-1130
Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles
Authors: de Fraissinette, AD Picarles, V Chibout, S Kolopp, M Medina, J Burtin, P Ebelin, ME Osborne, S Mayer, FK Spake, A Rosdy, M De Wever, B Ettlin, RA Cordier, A
Citation: Ad. De Fraissinette et al., Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles, CELL BIOL T, 15(2), 1999, pp. 121-135
Risultati: 1-3 |